Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13176-46-0

Post Buying Request

13176-46-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Hot Sales Ethyl 4-bromo-3-oxobutanoate CAS NO.13176-46-0 CAS NO.13176-46-0

    Cas No: 13176-46-0

  • USD $ 7.0-8.0 / Metric Ton

  • 1 Metric Ton

  • 1000 Metric Ton/Day

  • KAISA GROUP INC
  • Contact Supplier

13176-46-0 Usage

General Description

Ethyl 4-bromoacetoacetate is a chemical compound with the molecular formula C6H9BrO3. It is derived from acetoacetic acid and is commonly used as a reagent in organic synthesis to introduce the 4-bromoacetoacetate moiety into various molecules. Ethyl 4-bromoacetoacetate is often utilized in the preparation of pharmaceuticals, agrochemicals, and other fine chemicals. It possesses a bromine atom and an ester functional group, making it useful in a variety of reactions such as nucleophilic substitution, aldol condensation, and Michael addition. Ethyl 4-bromoacetoacetate is typically handled and used with caution due to its potential health hazards and its ability to cause skin and eye irritation.

Check Digit Verification of cas no

The CAS Registry Mumber 13176-46-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,7 and 6 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 13176-46:
(7*1)+(6*3)+(5*1)+(4*7)+(3*6)+(2*4)+(1*6)=90
90 % 10 = 0
So 13176-46-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H9BrO3/c1-2-10-6(9)3-5(8)4-7/h2-4H2,1H3

13176-46-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl 4-Bromoacetoacetate

1.2 Other means of identification

Product number -
Other names Ethyl 4-bromoacetoacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13176-46-0 SDS

13176-46-0Synthetic route

ethyl acetoacetate
141-97-9

ethyl acetoacetate

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
With bromine In dichloromethane at -5 - 5℃; for 2h;92.54%
With bromine; acetic acid at 0℃; for 1.16667h;85%
With bromine; acetic acid at 0℃; for 1.16667h;85%
ethyl acetoacetate
141-97-9

ethyl acetoacetate

A

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

B

ethyl 4-bromoacetoacetate

ethyl 4-bromoacetoacetate

Conditions
ConditionsYield
Stage #1: ethyl acetoacetate With bromine In acetic acid at 20℃; for 0.5h;
Stage #2: With hydroquinone In acetic acid at 20℃; for 1h; Further stages.;
A 90%
B 3%
With bromine In acetic acid at 20℃; for 3h;
4-methyleneoxetan-2-one
674-82-8

4-methyleneoxetan-2-one

ethanol
64-17-5

ethanol

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
Stage #1: 4-methyleneoxetan-2-one With bromine In dichloromethane at -20 - -10℃; Inert atmosphere;
Stage #2: ethanol With pyridine In dichloromethane at -10 - 20℃; for 1h; Inert atmosphere;
84%
With bromine 1.) CCl4; Multistep reaction;
With bromine at -30 - 5℃; for 1h;
ethyl bromoacetate
105-36-2

ethyl bromoacetate

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
With isopropylmagnesium bromide In diethyl ether77%
With samarium diiodide In tetrahydrofuran at -78℃;45%
ethyl 2-bromoacetoacetate
84911-18-2, 609-13-2

ethyl 2-bromoacetoacetate

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
zur Umlagerung ist ausser der Anwesenheit von HBr auch Belichtung oder Gegenwart von Luftsauerstoff oder Peroxyd erforderlich;
Bildung durch Umlagerung;
With hydrogen bromide; acetic acid at 100℃;
ethyl bromoacetate
105-36-2

ethyl bromoacetate

A

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

B

ethyl acetoacetate
141-97-9

ethyl acetoacetate

Conditions
ConditionsYield
With diethyl ether; iodine; magnesium Zersetzung des Reaktionsprodukts mit Schwefelsaeure;
n-butyllithium
109-72-8, 29786-93-4

n-butyllithium

ethyl bromoacetate
105-36-2

ethyl bromoacetate

A

1-bromo-2-hexanone
26818-07-5

1-bromo-2-hexanone

B

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

C

ethyl acetoacetate
141-97-9

ethyl acetoacetate

D

succinic acid diethyl ester
123-25-1

succinic acid diethyl ester

Conditions
ConditionsYield
With methanol In hexane at -60 - -50℃; for 1h; Product distribution; other temp.: -78 deg C;
water
7732-18-5

water

bromine
7726-95-6

bromine

ethyl acetoacetate
141-97-9

ethyl acetoacetate

CS2

CS2

A

ethyl 2-bromoacetoacetate
84911-18-2, 609-13-2

ethyl 2-bromoacetoacetate

B

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

bromoacetic acid methyl ester
96-32-2

bromoacetic acid methyl ester

magnesium compound of bromoacetic acid ethyl ester

magnesium compound of bromoacetic acid ethyl ester

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
With diethyl ether
ethyl bromoacetate
105-36-2

ethyl bromoacetate

A

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

B

ethyl acetate and acetoacetic acid ethyl ester

ethyl acetate and acetoacetic acid ethyl ester

Conditions
ConditionsYield
With aluminium; xylene
ethyl acetoacetate
141-97-9

ethyl acetoacetate

A

ethyl 2-bromoacetoacetate
84911-18-2, 609-13-2

ethyl 2-bromoacetoacetate

B

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

C

ethyl 2,2-dibromoacetoacetate
89415-67-8

ethyl 2,2-dibromoacetoacetate

Conditions
ConditionsYield
With bromine In acetic acid at 20℃; for 0.0166667h;
ethyl acetoacetate
141-97-9

ethyl acetoacetate

A

ethyl 2-bromoacetoacetate
84911-18-2, 609-13-2

ethyl 2-bromoacetoacetate

B

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
With N-Bromosuccinimide In diethyl ether at 30℃; for 3h; UV-irradiation;
acetoacetic acid methyl ester
105-45-3

acetoacetic acid methyl ester

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

Conditions
ConditionsYield
With bromine In chloroform at 0 - 20℃; for 17.5h; Inert atmosphere;
Cbz-L-proline thioamide
63808-47-9

Cbz-L-proline thioamide

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

C19H22N2O4S
320608-49-9

C19H22N2O4S

Conditions
ConditionsYield
In ethanol for 2h; Heating / reflux;100%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 1-methyl-2-oxoindolin-3-ylidenecarbamate
1373942-83-6

tert-butyl 1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-06-5

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Reagent/catalyst; Solvent; Time; Mannich Aminomethylation; enantioselective reaction;98%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;92%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Reagent/catalyst; Solvent; enantioselective reaction;92%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

triphenylphosphine
603-35-0

triphenylphosphine

(3-Ethoxycarbonyl-2-oxo-propyl)-triphenyl-phosphonium; bromide
13176-47-1

(3-Ethoxycarbonyl-2-oxo-propyl)-triphenyl-phosphonium; bromide

Conditions
ConditionsYield
In benzene for 18h; Ambient temperature;97%
for 24h;
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 5-methoxy-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-17-9

tert-butyl 5-methoxy-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-5-methoxy-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-11-2

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-5-methoxy-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;97%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 5-bromo-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-19-1

tert-butyl 5-bromo-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[5-bromo-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-13-4

tert-butyl (R)-[5-bromo-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;97%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 7-fluoro-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-22-6

tert-butyl 7-fluoro-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-7-fluoro-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-17-8

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-7-fluoro-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;97%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 7-chloro-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-23-7

tert-butyl 7-chloro-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[7-chloro-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-18-9

tert-butyl (R)-[7-chloro-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;97%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 7-bromo-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-24-8

tert-butyl 7-bromo-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[7-bromo-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-19-0

tert-butyl (R)-[7-bromo-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;97%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

C15H15F3N2O3
1432059-32-9

C15H15F3N2O3

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxo-7-(trifluoromethyl)indolin-3-yl]carbamate
1580515-20-3

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxo-7-(trifluoromethyl)indolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;97%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 5-methoxy-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-17-9

tert-butyl 5-methoxy-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1,5-dimethyl-2-oxoindolin-3-yl]carbamate
1580515-10-1

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1,5-dimethyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;97%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

triphenyl-arsane
603-32-7

triphenyl-arsane

(3-Ethoxycarbonyl-2-oxo-propyl)-triphenyl-arsonium; bromide

(3-Ethoxycarbonyl-2-oxo-propyl)-triphenyl-arsonium; bromide

Conditions
ConditionsYield
at 80℃; for 2h;96%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl (5-chloro-1-methyl-2-oxoindolin-3-ylidene)carbamate
1403338-22-6

tert-butyl (5-chloro-1-methyl-2-oxoindolin-3-ylidene)carbamate

tert-butyl (R)-[5-chloro-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-12-3

tert-butyl (R)-[5-chloro-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;96%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;96%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;96%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 6-chloro-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-20-4

tert-butyl 6-chloro-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[6-chloro-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-14-5

tert-butyl (R)-[6-chloro-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;96%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;96%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;96%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 6-bromo-1-methyl-2-oxoindolin-3-ylidenecarbamate
1373943-21-5

tert-butyl 6-bromo-1-methyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[6-bromo-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate
1580515-15-6

tert-butyl (R)-[6-bromo-3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-methyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;96%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;96%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;96%
N-phenyl-maleimide
941-69-5

N-phenyl-maleimide

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-phenylpyrrolidine-2,5-dione

3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-phenylpyrrolidine-2,5-dione

Conditions
ConditionsYield
With triethylamine In dichloromethane at 25℃; for 2h; Michael Addition;96%
N-phenylmaleimide
83-25-0

N-phenylmaleimide

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-phenylpyrrolidine-2,5-dione

3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1-phenylpyrrolidine-2,5-dione

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 2h; Michael Addition;96%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

S-tert-butyl sodium trithiocarbonate
71127-42-9

S-tert-butyl sodium trithiocarbonate

4-tert-Butylsulfanylthiocarbonylsulfanyl-3-oxo-butyric acid ethyl ester
90403-75-1

4-tert-Butylsulfanylthiocarbonylsulfanyl-3-oxo-butyric acid ethyl ester

Conditions
ConditionsYield
In acetone for 2h; Ambient temperature;95%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

(S)-4-bromo-3-hydroxy-butyric acid ethyl ester
32224-01-4, 95310-94-4, 128052-98-2, 95537-36-3

(S)-4-bromo-3-hydroxy-butyric acid ethyl ester

Conditions
ConditionsYield
With D-glucose; broth E. coli HB101; pNTS1G; NADP In various solvent(s) at 30℃; for 20h; pH=6.5; Enzymatic reaction;95%
Daucas carota root; extract of In water at 37 - 40℃; for 62h; pH=7.0; Conversion of starting material; Enzymatic reaction; Aqueous phosphate buffer;53%
With yeast pH=8 and further enzymes;
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

C15H18N2O3
1432059-33-0

C15H18N2O3

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1,7-dimethyl-2-oxoindolin-3-yl]carbamate
1580515-16-7

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1,7-dimethyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;95%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;95%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;95%
2-aminopyridine
504-29-0

2-aminopyridine

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

imidazo[1,2-α]pyridin-3-yl-acetic acid ethyl ester
101820-69-3

imidazo[1,2-α]pyridin-3-yl-acetic acid ethyl ester

Conditions
ConditionsYield
In 1,4-dioxane; water at 20 - 70℃; for 3.5h; Temperature; Time; Concentration; Reagent/catalyst;94.1%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

1-((10-ethyl-10H-phenothiazin-3-yl)methylidene)thiosemicarbazide
507277-64-7

1-((10-ethyl-10H-phenothiazin-3-yl)methylidene)thiosemicarbazide

ethyl 2-(2-(2-((10-ethyl-10H-phenothiazin-3-yl)-methylene)hydrazinyl)thiazol-4-yl)acetate
1393117-05-9

ethyl 2-(2-(2-((10-ethyl-10H-phenothiazin-3-yl)-methylene)hydrazinyl)thiazol-4-yl)acetate

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 60℃; under 1275.13 Torr; for 1.5h; Hantzsch cyclization; Microwave irradiation;94%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

4-bromo-2-diazo-3-oxobutyric acid ethyl ester
188475-10-7

4-bromo-2-diazo-3-oxobutyric acid ethyl ester

Conditions
ConditionsYield
With 4-acetamidobenzenesulfonyl azide; tert-butylamine In tetrahydrofuran at 25℃; Inert atmosphere;94%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl (2-oxo-1-phenylindolin-3-ylidene)carbamate
1443052-58-1

tert-butyl (2-oxo-1-phenylindolin-3-ylidene)carbamate

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-2-oxo-1-phenylindolin-3-yl]carbamate
1580515-09-8

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-2-oxo-1-phenylindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;93%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;93%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;93%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

tert-butyl 1,5-dimethyl-2-oxoindolin-3-ylidenecarbamate
1373943-16-8

tert-butyl 1,5-dimethyl-2-oxoindolin-3-ylidenecarbamate

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1,5-dimethyl-2-oxoindolin-3-yl]carbamate
1580515-10-1

tert-butyl (R)-[3-(2-ethoxy-4-oxo-4,5-dihydrofuran-3-yl)-1,5-dimethyl-2-oxoindolin-3-yl]carbamate

Conditions
ConditionsYield
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; Mannich Aminomethylation; enantioselective reaction;93%
With sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;93%
With C31H26F6N4O2; sodium carbonate In dichloromethane at 25℃; for 48h; enantioselective reaction;93%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

ethyl α,γ-dibromoacetoacetate
24499-76-1

ethyl α,γ-dibromoacetoacetate

Conditions
ConditionsYield
With pyrrolidone hydrotribromide In tetrahydrofuran for 3h;91%
1-benzyl-1H-pyrrole-2,5-dione
1631-26-1

1-benzyl-1H-pyrrole-2,5-dione

4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

C17H17NO5

C17H17NO5

Conditions
ConditionsYield
With sodium carbonate; Quinine In chloroform at 0℃; for 24h; enantioselective reaction;91%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

(2-nitroethenyl)benzene
102-96-5

(2-nitroethenyl)benzene

(R)-5-ethoxy-4-(2-nitro-1-phenylethyl)furan-3(2H)-one
1361938-46-6

(R)-5-ethoxy-4-(2-nitro-1-phenylethyl)furan-3(2H)-one

Conditions
ConditionsYield
With 1-(3,5-bis(trifluoromethyl)phenyl)-3-((2R,3R)-3-((tert-butyldimethylsilyl)oxy)-1-(piperidin-1-yl)butan-2-yl)thiourea; ammonium carbonate In toluene at 20℃; for 24h; Feist-Benary synthesis; optical yield given as %ee; enantioselective reaction;90%
4-bromoethyl acetoacetate
13176-46-0

4-bromoethyl acetoacetate

2,4-Xylenol
105-67-9

2,4-Xylenol

phosphorous acid trimethyl ester
121-45-9

phosphorous acid trimethyl ester

dimethyl (6,8-dimethyl-2-oxo-2H-chromen-4-yl)methylphosphoramidate

dimethyl (6,8-dimethyl-2-oxo-2H-chromen-4-yl)methylphosphoramidate

Conditions
ConditionsYield
Stage #1: 4-bromoethyl acetoacetate With sodium azide In ethanol at 20℃; for 0.166667h; Pechmann Condensation;
Stage #2: phosphorous acid trimethyl ester With iodine In ethanol at 20℃; for 0.333333h; Pechmann Condensation;
Stage #3: 2,4-Xylenol In ethanol for 3h; Pechmann Condensation; Reflux;
90%

13176-46-0Relevant articles and documents

Chromophore-linked substrate (CLS405): Probing metallo-β-lactamase activity and inhibition

Makena, Anne,Van Berkel, Sander S.,Lejeune, Clarisse,Owens, Raymond J.,Verma, Anil,Salimraj, Ramya,Spencer, James,Brem, Juergen,Schofield, Christopher J.

, p. 1923 - 1929 (2013)

Serine- and metallo-β-lactamases present a threat to the clinical use of nearly all β-lactam antibiotics, including penicillins, cephalosporins, and carbapenems. Efforts to develop metallo-β-lactamase (MBL) inhibitors require suitable screening platforms to allow the rapid determination of β-lactamase activity and efficient inhibition. Unfortunately, the platforms currently available are not ideal for this purpose. Further progress in MBL inhibitor identification requires inexpensive and widely applicable assays. Herein the identification of an inexpensive and stable chromogenic substrate suitable for use in assays of clinically relevant MBLs is described. (6R,7R)-3-((4-Nitrophenoxy)methyl)-8-oxo-7-(2-phenylacetamido) -5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5,5-dioxide (CLS405) was synthesised in a three-step protocol. CLS405 was then characterised spectroscopically, and its stability and kinetic properties evaluated. With a Δλmax value of 100 nm between the parent and hydrolysis product, a higher analytical accuracy is possible with CLS405 than with commonly used chromogenic substrates. The use of CLS405 in assays was validated by MBL activity measurements and inhibitor screening that resulted in the identification of N-hydroxythiazoles as new inhibitor scaffolds for MBLs. Further evaluation of the identified N-hydroxythiazoles against a panel of clinically relevant MBLs showed that they possess inhibitory activities in the mid- to low-micromolar range. The findings of this study provide both a useful tool compound for further inhibitor identification, and novel scaffolds for the design of improved MBL inhibitors with potential as antibiotics against resistant strains of bacteria. Monitoring MBLs! Resistance to β-lactam antibiotics, mediated by metallo-β-lactamases (MBLs), is an increasing clinical problem. While compounds that target MBLs could be useful antibacterial agents, their identification is hampered by the lack of suitable assay platforms. To this end, CLS405, a chromophore-linked MBL substrate, was developed and its applicability demonstrated by the identification of N-hydroxythiazoles as potential inhibitors against a panel of clinically relevant MBLs. Copyright

-

Kharasch,Sternfeld,Mayo

, p. 1655 (1937)

-

Fluorescence ratiometric zinc sensors based on controlled energy transfer

Woo, Hana,You, Youngmin,Kim, Taehee,Jhon, Gil-Ja,Nam, Wonwoo

, p. 17100 - 17112 (2012)

The high-fidelity detection of labile zinc is of central importance for understanding the molecular mechanisms that link zinc homeostasis and human pathophysiology. Fluorescence ratiometric sensors are most suitable for the detection and trafficking of intracellular zinc ions. Here, we report the development of fluorescence ratiometric zinc sensors (HN1 and HN2) based on two-fluorophore platforms. The sensor constructs include blue fluorescent umbelliferone and an energy-accepting chromophore that absorbs the blue fluorescence. Zinc binding was found to promote fluorescence turn-on of the umbelliferone emission by suppression of intramolecular photoinduced electron transfer, thereby facilitating resonance energy transfer to the energy acceptors. The net observables were the fluorescence ratiometric changes, the extent of which depended strongly on the chemical structures of the acceptors. Photophysical investigations, including steady-state and transient photoluminescence spectroscopy, suggested a mechanism for the fluorescent zinc response that involved a combination of the intramolecular electron transfer and the interchromophoric energy transfer. The zinc probes displayed sensing capability that is suitable for the detection of biological zinc ions, with good selectivity, pH tolerance, and appropriate Kd values. Finally, zinc detection was demonstrated by fluorescence ratiometric visualization of exogenously supplied zinc ions in live HeLa cells. The probes enabled the reliable monitoring of zinc equilibration across the cell membrane. The Royal Society of Chemistry 2012.

Facile synthesis of β-ketoesters mediated by Sml2: Reformatsky reaction type selfcondensation

Park, Heui Sul,Lee, In Sang,Kim, Yong Hae

, p. 1673 - 1674 (1995)

α-Bromoesters are converted to β-ketoesters by treatment with samarium diiodide via self condensation under the mild conditions. The reaction appears to be initiated via the formation of samariun diiodide ester enolate for the Reformatsky reation type.

Target-Directed Azide-Alkyne Cycloaddition for Assembling HIV-1 TAR RNA Binding Ligands

Dash, Jyotirmayee,Dutta, Debasish,Paul, Raj,Paul, Rakesh

, p. 12407 - 12411 (2020)

The highly conserved HIV-1 transactivation response element (TAR) binds to the trans-activator protein Tat and facilitates viral replication in its latent state. The inhibition of Tat–TAR interactions by selectively targeting TAR RNA has been used as a strategy to develop potent antiviral agents. Therefore, HIV-1 TAR RNA represents a paradigmatic system for therapeutic intervention. Herein, we have employed biotin-tagged TAR RNA to assemble its own ligands from a pool of reactive azide and alkyne building blocks. To identify the binding sites and selectivity of the ligands, the in situ cycloaddition has been further performed using control nucleotide (TAR DNA and TAR RNA without bulge) templates. The hit triazole-linked thiazole peptidomimetic products have been isolated from the biotin-tagged target templates using streptavidin beads. The major triazole lead generated by the TAR RNA presumably binds in the bulge region, shows specificity for TAR RNA over TAR DNA, and inhibits Tat–TAR interactions.

A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1

Li, Ke,Krueger, Sarah B.,Zimmerman, Steven C.

, p. 2638 - 2644 (2021)

Myotonic dystrophy type 1 (DM1) is a multisystemic neuromuscular disorder that is inherited in an autosomal dominant manner. DM1 originates in a (CTG?CAG) repeat expansion in the 3’-UTR of the dystrophia myotonic protein kinase (DMPK) gene on chromosome 19. One of the transcripts, r(CUG)exp, is toxic in various ways. Herein we report a rationally designed small molecule with a thiazole peptidomimetic unit that can serve as a minor groove binder for the nucleic acid targets. This peptide unit linked to two triaminotriazine recognition units selectively binds to d(CTG)exp to inhibit the transcription process, and also targets r(CUG)exp selectively to improve representative DM1 pathological molecular features, including foci formation and pre-mRNA splicing defects in DM1 model cells. As such, it represents a new structure type that might serve as a lead compound for future structure-activity optimization.

Imidazo[1,2-a]pyridin-2-ylacetic acid and two pairs of isomorphous ML 2(H2O)2 dihydrates (M = Ni, Co and Mn, Cd) based on its anion: Syntheses, crystal structures and properties

Dylong, Agnieszka,Sowa, Micha?,Goldeman, Waldemar,?lepokura, Katarzyna,Duczmal, Marek,Wojciechowska, Agnieszka,Matczak-Jon, Ewa

, p. 9 - 21 (2014)

Imidazo[1,2-a]pyridin-2-ylacetic acid (HL, 1) and four ML 2(H2O)2·2H2O (M = Ni (2), Co (3), Mn (4), Cd (5)) complexes formed by its anion were synthesized, structurally characterized by single-crystal X-ray diffraction and investigated in terms of their thermal stability. In addition, magnetic properties of 2-4 are reported and the NIR-Vis-UV spectra of 2 and 3 are discussed in details. The crystal of 1 comprises 2D hydrogen bonded networks held in the crystal lattice by weak C-H.

Phosphine-Mediated Iterative Arene Homologation Using Allenes

Zhang, Kui,Cai, Lingchao,Jiang, Xing,Garcia-Garibay, Miguel A.,Kwon, Ohyun

, p. 11258 - 11261 (2015)

A PPh3-mediated multicomponent reaction between o-phthalaldehydes, nucleophiles, and monosubstituted allenes furnishes functionalized non-C2-symmetric naphthalenes in synthetically useful yields. When the o-phthalaldehydes were reacted with 1,3-disubstituted allenes in the presence of PPh2Et, naphthalene derivatives were also obtained in up to quantitative yields. The mechanism of the latter transformation is straightforward: aldol addition followed by Wittig olefination and dehydration. The mechanism of the former is a tandem γ-umpolung/aldol/Wittig/dehydration process, as established by preparation of putative reaction intermediates and mass spectrometric analysis. This transformation can be applied iteratively to prepare anthracenes and tetracenes using carboxylic acids as pronucleophiles.

Design, synthesis, molecular docking, anti-proliferative and anti-TB studies of 2H-chromen-8-azaspiro[4.5]decane-7,9-dione conjugates

Mane, Smita G.,Reddy, Dinesh S.,Katagi, Kariyappa S.,Kumar, Amit,Munnolli, Ravindra S.,Kadam, Nikhil S.,Akki, Mahesh C.,Nagarajaiah,Joshi, Shrinivas D.

, (2021)

In this work, a series of new 8-[(substituted 2-oxo-2H-chromen-4-yl)methyl]-8-azaspiro[4.5]decane-7,9-dione derivatives (1a - 1l) is synthesized and characterized by 1H NMR, 13C NMR, FT-IR, GC-MS and elemental analysis. In addition, the structure of compound 1k has been elucidated using single crystal X-ray diffraction techniques. The synthesized compounds are screened for their anticancer and anti-TB activity. Preliminary anticancer results showed that compounds (1a- 1l) exhibit moderate to potent activity against MDA-MB-231, A549, HT-29 and Hela cancer cell lines. Compound 1f exhibited the most potent activity against MDA-MB-231cell line with IC50 value of 9.05 μM concentration, compound 1g and 1h showed potent activity against A549 cell line with IC50 value of 7.05 and 13.31 μM concentration respectively. Compound 1j showed good cytotoxicity against Hela cell line with IC50 of 16.14 μM, whereas, compound 1l is found to be moderately active against HT-29 cell line with IC50 of 18.07 μM. Anti-tubercular activity revealed that compound 1c, 1d, 1g, 1h and 1j have significant activity against MTBH37Rv strain with MIC 0.78, 1.56, 0.19, 0.39 and 0.78 μg/mL respectively. Further, to investigate the mechanism of anti-TB activity and detailed intermolecular interactions between the synthesized compounds, molecular docking studies are performed.

Microwave facilitated one-pot three component synthesis of coumarin-benzoxazole clubbed 1,2,3-triazoles: Antimicrobial evaluation, molecular docking and in silico ADME studies

Nesaragi, Aravind R.,Kamble, Ravindra R.,Bayannavar, Praveen K.,Metre, Tukaram V.,Kariduraganavar, Mahadevappa Y.,Margankop, Sheetal B.,Joshi, Shrinivas D.,Kumbar, Vijay M.

, p. 3460 - 3472 (2021/10/02)

4-((4-((Benzo[d]oxazol-2-ylthio)methyl)-1H-1,2,3-triazol-1-yl)methyl)-2H-chromen-2-ones 7k–z were synthesized by conventional as well as microwave irradiation method in order to obtain antimicrobial agents. The present green synthetic protocol explores facile work up procedure with excellent yields (82–92%) and purity. Docking studies exhibited strong binding interactions with enzyme N-myristoyl transferase (PDB ID: 4CAW) with excellent C-score values. Compounds 7k–z were screened for their in vitro antimicrobial activities. The compounds 7w and 7 y exhibited excellent antimicrobial results for all the tested microorganisms at MICs ranging from 3.12 to 6.25 μg/ml in comparison with the marketed drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13176-46-0